Gut Microbiome clinical trials at UC Davis
2 research studies open to eligible people
“The purpose of this study is to determine if giving a probiotic for 28 consecutive days increases levels of that probiotic in infants’ stool”
open to eligible people ages 2 months to 4 months
The REMEDI Study is a single-center, prospective, double-blind, randomized, placebo-controlled trial of multiple doses of B. infantis EVC001 supplementation in healthy term breastfed infants.
“The purpose of this study is to determine if dietary fiber increases overall gut health”
open to eligible people ages 18-45
The objective of this project is to conduct a randomized-order, double-blinded cross-over trial in 20 participants to test the effects of a dietary fiber formulation on gut microbiota composition and short chain fatty acid production, lipid profiles, glucose sensitivity, intestinal permeability, overall gut health, and markers of inflammation.